The bactericidal action of silver (0) nanoparticles and amoxicillin on Escherichia coli is studied, respectively. Increasing concentration of both amoxicillin (0-0.525 mg ml −1 ) and silver nanoparticles (0-40 µg ml −1 ) showed a higher antibacterial effect in Luria-Bertani (LB) medium. Escherichia coli cells have different bactericidal sensitivity to them. When amoxicillin and silver nanoparticles are combined, it results in greater bactericidal efficiency on Escherichia coli cells than when they were applied separately. Dynamic tests on bacterial growth indicated that exponential and stationary phases are greatly decreased and delayed in the synergistic effect of amoxicillin and silver nanoparticles. In addition, the effect induced by a preincubation with silver nanoparticles is examined. The results show that solutions with more silver nanoparticles have better antimicrobial effects. One hypothesized mechanism is proposed to explain this phenomenon.
Introduction
Since the discovery of penicillin, β-lactam antibiotics have become the most important spectrum of antibacterial agents [1, 2] . However, the empirical therapy and broad use of these agents have caused the bacteria to produce different kinds of β-lactamases (β-Lases), which could lead to the spread of bacterial resistance [3] [4] [5] [6] . Thus clinical efficacy of β-lactam antibiotics was compromised. β-lactam antibiotic resistance has become a serious problem that challenges the health of human beings [7] [8] [9] [10] .
As a result, increasingly more pressure has been put on pharmaceutical researchers and medical scientists to develop new antibiotics [11] . Some approaches have been reported for overcoming the bacterial resistance. One was to alter the structure of β-lactam to decrease its sensitivity to the hydrolysis by β-Lases [12] . Another method was to use dual action cephems; if bacteria have resistance to one of them, the other antimicrobial agent would kill them in another way [13] [14] [15] [16] . Vergauwe and colleagues used reagents such as 3 Author to whom any correspondence should be addressed. clavulanic acid to incapacitate the β-Lases [17] . In all these methods, reagents added to overcome the bacterial resistance were organic chemicals. Inorganic elements or compounds were seldom used in the antimicrobial industry. However, it is well known that inorganic nanomaterials are good antimicrobial agents. In recent reports, there were a few papers which began to study the antimicrobial effects of combining β-lactam and inorganic nanomaterials. This research would be invaluable for developing novel antimicrobial agents.
In all inorganic antimicrobial agents, silver elements and compounds of nanoparticles were the most extensively tested ones. Recently, Sondi and Salopek-Sondi proved that silver (0) nanoparticles (nanosilver) were quite good antimicrobial agents against Escherichia coli [18] . In addition, nanosilver has excellent properties of conformational entropy in polyvalent binding [19, 20] , which make it easy to attach to flexible polymeric chains of antibiotics. Moreover, nanosilver possesses well developed surface chemistry, chemical stability, and appropriate size (20 nm in diameter, 250 times smaller than a bacterium). It is able to maintain constant shape and size in solution. Thus it is a good choice to use nanosilver as inorganic nanomaterials in combination with β-lactam, as the inorganic nanomaterials against E. coli cells.
Materials and methods

Materials
Escherichia coli strain F220 was obtained from our laboratory. LB medium used was prepared as reported in the literature [21] [22] [23] [24] . The chemicals such as ascorbic acid, silver nitrate, ammonia and acetic acid were all A.R. reagents purchased from Shanghai Chemical Reagent Corporation, while sodium dodecyl sulfate (SDS) was bought from Sigma Corporation. These reagents were used without any pretreatment.
Preparation of silver nanoparticles
Silver nanoparticles are prepared by reducing AgNO 3 aqueous solution with freshly prepared ascorbic acid aqueous solution using a modified method as described previously [18, 25] + solution with a velocity of 120 rpm. The colour of the solution changed from colourless to blackish-grey after 1 h, which indicated the appearance of Ag nanoparticles. The cleaned silver nanoparticles were resuspended in the ethanol after the solution was ultrasonicated at 100 W for 2 min and sequentially centrifuged with distilled, de-ionized water and ethanol at 15 000 rpm for 30 min. Part of the resuspended solution was preserved for further characterization and the rest was freeze-dried to be Ag powder. Ag powder was dispersed in ultrapure water to achieve desired concentration.
Bacterial susceptibility testing
The inocula of Escherichia coli were prepared by growing test strains in LB medium at 37
• C until approximately 10 8 -10 9 CFU of bacteria were reached. The cultures were filtrated twice and the cells were washed and suspended in distilled water until the inocula reached approximately 5.0 × 10 6 CFU. The cells were incubated in LB medium with 0.000, 0.150, 0.300, 0.375, 0.450 and 0.525 mg ml −1 amoxicillin, shaken at 37
• C for 24 h. The same procedure was performed with 0, 5, 10, 15, 20, 25, 30, 35 and 40 µg ml −1 of nanosilver. The minimal inhibition concentrations (MICs) of amoxicillin and nanosilver were calculated respectively. To get the MIC of the mixture of amoxicillin and nanoparticles, the cells of the bacteria were spotted into LB medium and incubated under different conditions as follows: 0.150 mg ml −1 amoxicillin + 5 µg ml −1 nanosilver and 0.150 mg ml −1 amoxicillin + 10 µg ml −1 nanosilver instead of amoxicillin or nanosilver alone. All assays were carried out in three duplicates in an effort to eliminate other random factors. Broth dilution experiments were conducted at 37
• C and performed in 204 well brushed plates. All stock solution was made in an LB agarose plate and diluted twofold with the duplicates. The MICs of amoxicillin and nanosilver, individually and jointly, were determined.
Bacterial testing of growth curve
To examine the bacterial growth rate in the presence of different antibiotics, E. coli cells were grown in 100 ml of liquid LB medium supplemented with 0.150 mg ml −1 amoxicillin, 5 µg ml −1 nanosilver and 0.150 mg ml −1 amoxicillin + 5 µg ml −1 nanosilver, respectively. Growth rates and bacterial concentrations were determined by measuring optical density (OD) at 600 nm. Then the OD values were changed into concentration of E. coli cells. Statistical analysis was conducted on the experimental results. In the analysis, R 1 represents the regression coefficient between the curve of silver nanoparticles and the curve of silver nanoparticles combined with amoxicillin, R 2 represents the regression coefficient between the curve of amoxicillin and the curve of combined antimicrobial agent (silver nanoparticles + amoxicillin).
Bacterial preincubation with silver nanoparticles
5.0 × 10 6 CFU Escherichia coli cells were first incubated in 5 µg ml −1 nanosilver for 12 h. After this, 0.150 mg ml
amoxicillin was added to LB medium. Broth dilution experiments were used to calculate the inocula of E. coli.
Characterization of nanosilver
The opto-electronic properties of the silver hydrosols were measured by ultraviolet-visible absorption spectra (UV-vis, Agilent, 8453). The size and morphology of the products were observed by transmission electron microscope (TEM, Hitachi, H-800). Samples for TEM imaging were prepared on 100-mesh Formvar-coated copper grids (Electron Microscopy Sciences). The sample size was carried out from transmission electron micrographs using the software Image Tool for Windows (Version 2.0). Data were analysed using software Microcal Origin 7.0. Figure 1 shows the TEM micrographs of silver nanoparticles. The shape of these nanoparticles was close to being cubic and the average diameter was about 20 nm. At room temperature, the UV-vis absorbance shown in figure 2 demonstrated a well defined band at 409 nm, characteristic of nanoscale silvers.
Results
As the particle size decreased, the absorption edge shifted to a higher energy state (blue shift), which was due to the quantum size effect. The blue shift was about 38 nm. In addition, the graph of absorbance of nanosilver hydrosols immediately after the precipitation process and the freeze-drying in de-ionized water indicated both samples of nanosilver were dispersed well and in stable condition. The MIC of amoxicillin tested in the experiment shown in figures 3 and 4 is about 0.525 mg ml −1 . In figures 5 and 6, the MIC of nanosilver appeared to be 40 µg ml −1 . It is clear from figures 3 and 5 that amoxicillin less than 0.375 mg ml −1 and nanosilver less than 30 µg ml −1 have no significant antimicrobial effect. However, 0.150 mg ml −1 amoxicillin plus 5 µg ml −1 nanosilver can achieve the same antibacterial efficiency of 0.525 mg ml −1 amoxicillin or that of 40 µg ml −1 nanosilver (figures 7 and 8). Comparing the individual antibacterial effect of amoxicillin or nanosilver with their combination, the augmentative antibacterial efficiency by the β-lactam antibiotic in combination with nanosilver is quite obvious. Either the 0.15 mg ml −1 amoxicillin or the 5 µg ml −1 nanosilver alone had hardly any effect on E. coli as demonstrated from this experiment.
The dynamics of bacterial growth was also monitored in liquid LB medium supplemented with 5 × 10 6 CFU of E. coli cells in 0.150 mg ml −1 amoxicillin and 5 µg ml nanosilver, separately or jointly. In figure 9 , 5 µg ml cells than either of the two antibacterial reagents applied alone. This experiment provided solid evidence of the synergistic antibacterial effect of amoxicillin with nanosilver. Further statistical analysis showed that the R 1 value was 0.906 and the R 2 value was 0.823. From the results, we can conclude that the antimicrobial effect of silver nanoparticles is the key contributor to that of silver nanoparticles combined with amoxicillin. The effect induced by preincubation with silver nanoparticles indicates that their antimicrobial effect is not as good as that of co-incubation, because the co-incubation could kill almost all 5 × 10 6 CFU of E.coli cells, while the preincubation could only achieve approximately 3 × 10 4 CFU. 
Discussion
Up to now, scientists have established the antibacterial mechanism of β-lactam antibiotics [26] [27] [28] . There has not been a consistent explanation on the antimicrobial mechanism of silver although the silver application on burning therapy has existed for more than a century [29, 30] . Some hypotheses indicated that catalytic oxidation of silver ions, with nascent oxygen, reacts with bacterial cell membranes, leading to cell death. More recently, Batarseh's research showed that the silver bactericidal effect was caused by silver (I) chelation preventing DNA from unwinding [31] . Nanosilver is composed of silver (0) atoms. Comparing silver (I) ions, nanosilver is larger in size, which makes it react with more molecules. The larger chelate compounds can produce different antimicrobial effects. To explain the mechanism of the synergistic antibacterial effect of amoxicillin with nanosilvers, in combination with the previous results and the properties of nanosilvers, we present a new hypothesis as follows.
(1) As discussed above, nanosilvers and amoxicillin can kill bacteria with a different mechanism. If bacteria have resistance to one of them, another antimicrobial agent would kill the bacteria in a quite different way. This plays an important role especially when the bacteria gain antimicrobial resistance. (2) If there is no antimicrobial resistance in bacteria, the synergistic effect may be caused by a bonding reaction between amoxicillin and nanosilver. Amoxicillin molecules contain many active groups such as hydroxy and amido groups. These groups react easily with nanosilver by chelation. Amoxicillin molecules themselves can bind each other through van der Waals interaction and other weak bonds. Ultimately, the antimicrobial groups come into being, which are made up of a nanosilver core and the surrounding amoxicillin molecules (shown in figure 10 ). Whenever antimicrobial groups act on one point at the surface of the bacterial cells they cause more destruction. Thus, the process of antimicrobial group forming is actually that of increasing the antimicrobial agents' concentration. (3) A more probable cause of the synergistic effect may be the action of nanosilver's drug carrier. To our knowledge, cell membrane consists of phospholipids and glycoprotein, which are all hydrophobic groups. Nanosilver, but not amoxicillin, is likely to approach the membrane of the target cells because amoxicillin molecules are hydrophilic and nanosilver is not. Therefore, antimicrobial groups facilitate the transport of amoxicillin to the cell surface. (4) As Batarseh concluded, silver chelates prevent the DNA from unwinding [31] . When nanosilver's antimicrobial groups react with the DNA, more molecules hold back the DNA unwinding, which results in more serious damage to the cells. Figure 11 shows a possible process of the synergistic effect of nanosilver and amoxicillin on bacterial cells.
Conclusions
In conclusion, the results of our study show that the combination of nanosilver and amoxicillin has a synergistic antibacterial efficiency on E. coli. We present a hypothesis to explain the antimicrobial mechanism. This research, though very preliminary, provides helpful insights to the development of novel antimicrobial agents. It is necessary to perform further investigations on the efficiency of nanosilver against bacteria other than E. coli, and on the joint effect of nanosilver and antibiotics other than amoxicillin. To elucidate the mechanism of this synergistic antibacterial effect, more elaborate experimental evidences will be needed.
